E6AP promotes prostate cancer by reducing p27 expression-Reference-Cited by-同舟云学术

E6AP promotes prostate cancer by reducing p27 expression

Published:2017-04-19 Issue:26 Volume:8 Page:42939-42948
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Raghu Dinesh¹²,Paul Piotr Jan¹²,Gulati Twishi¹²,Deb Siddhartha³,Khoo Christine⁴,Russo Andrea⁵,Gallo Enzo⁵,Blandino Giovanni⁶,Chan Ai-Leen²⁷,Takano Elena⁴,Sandhu Shahneen K.⁸,Fox Stephen B.⁴,Williams Scott⁹,Haupt Sue¹²,Gamell Cristina¹²,Haupt Ygal¹²¹⁰¹¹

Affiliation:

1. The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia

2. Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

3. Anatpath Services Pty Ltd, Gardenvale, Victoria, Australia

4. Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

5. Department of Surgical Pathology, Regina Elena Cancer Institute, Rome, Italy

6. Oncogenomic and Epigenetic Unit, Italian National Cancer Institute, Rome, Italy

7. Current address: Australian Regenerative Medicine Institute, Monash University, Melbourne, Victoria, Australia

8. Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

9. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

10. Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia

11. Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1;Medical Oncology;2024-01-28

2. Structural insights into viral hijacking of p53 by E6 and E6AP;2023-11-02

3. Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors;BioFactors;2023-05-10

4. Functional roles of E3 ubiquitin ligases in prostate cancer;Journal of Molecular Medicine;2022-07-11

5. The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors;Cell Death & Disease;2022-04-02